Paul Scigalla

Chief Tech/Sci/R&D Officer at GENELUX CORPORATION

79 year

Health Technology

Consumer Services

Finance

Paul Scigalla active positions

Companies	Position	Start	End
GENELUX CORPORATION	Chief Tech/Sci/R&D Officer	2011-08-31	-
Ruprecht-Karls-Universität Heidelberg	Corporate Officer/Principal	1991-12-31	-

Companies	Position	Start	End
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.	Corporate Officer/Principal	1997-12-31	2000-12-31
NUEVOLUTION AB (PUBL)	Chief Tech/Sci/R&D Officer	2017-12-31	-
DEUTSCHE BIOTECH INNOVATIV AG	Chief Tech/Sci/R&D Officer	-	-

Humboldt-Universität zu Berlin

Doctorate Degree

International

Operational

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
DEUTSCHE BIOTECH INNOVATIV AG	Finance
GENELUX CORPORATION	Health Technology

Private companies	2
Nuevolution AB Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark.	Health Technology
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.	Health Technology

Private companies

Health Technology